At the end of the latest market close, Selecta Biosciences Inc. (SELB) was valued at $2.62. In that particular session, Stock kicked-off at the price of $2.60 while reaching the peak value of $2.67 and lowest value recorded on the day was $2.51. The stock current value is $2.60.
Recently in News on August 6, 2020, Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Updates. Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform, ImmTOR, today reported financial results for the second quarter ended June 30, 2020 and provided corporate updates. You can read further details here
Selecta Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.83 on 02/10/20, with the lowest value was $1.42 for the same time period, recorded on 03/19/20.
Selecta Biosciences Inc. (SELB) full year performance was 46.07%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Selecta Biosciences Inc. shares are logging -46.17% during the 52-week period from high price, and 103.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.28 and $4.83.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1119167 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Selecta Biosciences Inc. (SELB) recorded performance in the market was 9.24%, having the revenues showcasing -31.94% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 272.19M, as it employees total of 27 workers.
The Analysts eye on Selecta Biosciences Inc. (SELB)
During the last month, 7 analysts gave the Selecta Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.91, with a change in the price was noted +0.65. In a similar fashion, Selecta Biosciences Inc. posted a movement of +33.33% for the period of last 100 days, recording 1,846,393 in trading volumes.
Technical rundown of Selecta Biosciences Inc. (SELB)
Raw Stochastic average of Selecta Biosciences Inc. in the period of last 50 days is set at 37.96%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 58.18%. In the last 20 days, the company’s Stochastic %K was 56.97% and its Stochastic %D was recorded 48.08%.
Considering, the past performance of Selecta Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 9.24%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -29.73%, alongside a boost of 46.07% for the period of the last 12 months. The shares increased approximately by 11.59% in the 7-day charts and went up by 9.24% in the period of the last 30 days. Common stock shares were lifted by -31.94% during last recorded quarter.